Important note: Information in this article was accurate in 1998. The state of the art may have changed since the publication date.
 |
AIDS TREATMENT NEWS Issue #301, August 21, 1998
John S. James
* October 1 is the deadline for abstract submission, if you want to present research at the conference. Applicants will be told at the end of October if their presentation was accepted. (For the late-breaker deadline, see below.)
* Accepted authors can apply for preferential registration and housing--but only between November 2 and November 20. Those who apply in this time will almost certainly be able to register.
* For other researchers and clinicians, registration opens November 23--and closes when registration reaches 3,200, or on December 31. This means that the November 23 date is the most important for researchers and clinicians who want to attend but either did not submit an abstract, or were rejected. It is possible that the remaining slots could fill within days.
* The late breaker abstract deadline is January 5. Late breaker submission is only for new information which was not available at the October 1 regular deadline. In addition, it is usually much more difficult to get a late-breaker submission accepted.
* For press, community, and scholarship applicants, deadlines are not yet available; check occasionally on the Web site below.
"A limited number of slots have been reserved for: (1) press, (2) community advocates, and (3) senior marketing personnel who provide liaison functions within their companies (please consult the Preliminary Program available in August for further details on these categories)...
"A limited number of scholarships will be available for fellows-in-training and community advocates. Please consult the conference Web site in August for further information." (Quotes are from conference brochure.)
The 6th Conference on Retroviruses and Opportunistic Infections is "sponsored by The Foundation for Retrovirology and Human Health, in scientific collaboration with the National Institute of Allergy and Infectious Diseases and the Centers for Disease Control and Prevention."
For more information check the Web site at www.retroconference.org; or use the faxback service at 800- 510-0319 or 703-716-7348 (you need to call from a fax machine, to receive the information by fax); or call the conference secretariat, Westover Management Group, 703-684- 4876, fax 703-684-4841, email info@retroconference.org.
980821
ATN30102
Copyright © 1998 - AIDS Treatment News. Permission granted for noncommercial reproduction, provided that our address and phone number are included if more than short quotations are used. Subscription lists are kept confidential. AIDS Treatment News, Subscription and Editorial Office: 1233 Locust St., 5th floor Philadelphia, PA 19107 800/TREAT-1-2 toll-free email: aidsnews@critpath.org http://www.aidsnews.org
Subscription Information: Call 800/TREAT-1-2: Businesses, Institutions, Professionals: $270/year. Includes early delivery of an extra copy by email. Nonprofit organizations: $135/year. Includes early delivery of an extra copy by email. Individuals: $120/year, or $70 for six months. Special discount for persons with financial difficulties: $54/year, or $30 for six months. If you cannot afford a subscription, please write or call. Outside North, Central, or South America, add air mail postage: $20/year, $10 for six months. Back issues available. Fax subscriptions, bulk rates, and multiple subscriptions are available; contact our office for details. Please send U.S. funds: personal check or bank draft, international postal money order, or travelers checks. VISA, Mastercard, and purchase orders also accepted. ISSN # 1052-4207
AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 1998. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 1998. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .